Tandem Diabetes Care (Nasdaq:TNDM) announced today that it appointed two new independent members to its board of directors.
Myoung Cha and Joao Malagueira have been named to the San Diego-based automated insulin delivery technology developer’s board, effective yesterday, June 15, 2022.
Get the full story at our sister site, Drug Delivery Business News.